Our study revealed that CML-HMGB1 correlates with oxidized HMGB1 and promotes cancer malignancy more than oxidized HMGB1, but its structural differences and receptor affinity have not been clarified. Here, HMGB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.